Literature DB >> 23050825

Antibodies in research of thymosin β4: investigation of cross-reactivity and influence of fixatives.

Jana Knop1, Christine App, Ewald Hannappel.   

Abstract

Antibodies against thymosin β4 are available from various sources and have been used in immunohistochemistry, ELISA, and Western blot analyses. None of these antibodies have been fully characterized for specificity and influence of fixation techniques. This presents a difficulty because many tissues express more than one member of the β-thymosin family; in addition, highly homologous sequences are typical elements of β-thymosins. It is also important to scrutinize the influence of fixatives on the antibody-binding capability. Fixatives such as formaldehyde are well known as cross-linking reagents. Chemical modifications within the thymosin β4 molecule might change the putative epitope recognized by the antibody. These considerations suggest that investigations on thymosin β4 antibodies available to the scientific community are important and necessary before any experiment can be performed to exclude cross-reactivity with other β-thymosins that are coexistent in the examined tissue and to prove antibody binding after fixation steps.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050825     DOI: 10.1111/j.1749-6632.2012.06659.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  1 in total

1.  Loss of endogenous thymosin β4 accelerates glomerular disease.

Authors:  Elisavet Vasilopoulou; Maria Kolatsi-Joannou; Maja T Lindenmeyer; Kathryn E White; Michael G Robson; Clemens D Cohen; Neil J Sebire; Paul R Riley; Paul J Winyard; David A Long
Journal:  Kidney Int       Date:  2016-08-26       Impact factor: 10.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.